N/A
N=74
Dexmedetomidine in Spinal Anesthesia
Blood Pressure · Anxiety
Bottom Line
View on ClinicalTrials.gov: NCT02155010 ↗Enrolled (actual)
74
Serious AEs
0.0%
Results posted
Sep 2016
Primary outcome: Primary: Incidence of Hypotension — 15; 5 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Dexmedetomidine (Drug); Dexmedetomidine with heavy bupivacaine (Drug)
- Age
- Adult · 20+ yrs
- Sex
- All
- Sponsor
- Inje University
- Primary completion
- Jul 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Incidence of Hypotension |
15; 5 | — |
| SECONDARY Patient's Anxiety |
43.65; 45.52; 37.03; 38.55; 34.90; 34.55 | — |
Summary
Patients were randomized into two groups, A group and B group. A group and B group patients are injected intravenous dexmedetomidine after intrathecal injection (IT) of heavy bupivacaine and injected intravenous dexmedetomidine before IT of heavy bupivacaine, respectively.
The investigators will compare of hemodynamics and patient's comfortability between two groups.
Eligibility Criteria
Inclusion Criteria
- 20 - 60 aged patients
- orthopedic operation undergoing spinal anesthesia
Exclusion Criteria
- more than American society of anesthesiologists classification 3
- hypertension
- diabetes mellitus
- heart disease (bradycardia, atrioventricular block)
Data sourced from ClinicalTrials.gov (NCT02155010). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.